TickerFacts.

OSR Health, Inc. (OSRH): Cost of Revenue

Annual figures by period end, from SEC filings.

$2.31M
Year ended 2025-12-31
$1.17M
Trailing 12 months to 2026-06-30
$2.72M2024-12-31: $2.72M2025-12-31: $2.31M$2.31M
2024-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$2.31M-14.9%2026-03-31, From 2025-01-01
2024-12-31$2.72Mn/a2026-03-31, From 2024-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
OSR Health, Inc. (OSRH)2025-12-31$2.31M-14.9%
QHSLab, Inc. (USAQ)2025-12-31$880.9K+13.8%
Nuo Therapeutics, Inc. (AURX)2025-12-31$1.10M+261.8%
IceCure Medical Ltd. (ICCM)2025-12-31$2.15M+17.0%
Femasys Inc (FEMY)2025-12-31$872.4K+60.1%
Tenon Medical, Inc. (TNON)2025-12-31$1.59M+1.3%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$2.17M+19.9%
Vycor Medical Inc (VYCO)2025-12-31$302.3K+81.2%
Lucid Diagnostics Inc. (LUCD)2025-12-31$6.67M-6.0%

Compare OSRH, USAQ, AURX, ICCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗